Hendrik Tevaearai

Hendrik studied medicine in Lausanne, where he trained as cardiovascular surgeon (FMH). He is a professor at the University of Bern, where he developed and led a large group of fundamental, technical, and clinical researchers. In 2008, he founded Swiss Cardio Technologies, a pharmaceutical start-up specializing in an innovative heart medication that recently received market authorization. Hendrik is now independent consultant for medical and medtech companies seeking specific expertise in all aspects of translational development, including R&D, IP, strategic and structural development, and regulatory affairs.